Heraf udledtes, at 160- 320 mg valsartan gav klinisk relevante reduktioner af UAE hos hypertensive patienter med type - diabetes.
It was concluded that 160-320 mg of valsartan produced clinically relevant reductions in UAE in hypertensive patients with type 2 diabetes.